Checkpoint Inhibition and Challenges for the Future in Immunotherapy

2015中国生物制品年会暨第十五次全国生物制品学术研讨会——This chapter is mainly introduces Immunotherapy and Checkpoint Blockade;who Benefits from Checkpoint Blockade Treatment;Combination Opportunities and challenges;Innovent is Therapeutic Anti-PD-1 Antibody for Oncology.


关键词: Checkpoint Blockade Treatment;Anti-PD-1 Antibody;Immunotherapy 2015中国生物制品年会暨第十五次全国生物制品学术研讨会

主讲人:Associate Director Andy Tsun 机构:Biologics Discovery, Innovent Biologics Inc.

时长:0:16:16 年代:2015年